Axol Bioscience Ltd.

Axol Bioscience Ltd. company information, Employees & Contact Information

Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research. We operate across five key areas, neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation), pain & sensation, ophthalmology (Dry-AMD, ophthal-inflammation), dermatology, and cardiovascular. Axol offers scalable solutions including iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control. The company is committed to closing the translational gap, developing physiologically relevant in vitro systems that improve consistency and relevance in human disease modeling and compound testing. Axol is recognized for its scientific excellence, transparent collaboration, and rigorous quality standards, with manufacturing operations certified to ISO 9001:2015.

Company Details

Employees
54
Address
Axol Bioscience Ltd, Meditrina Building, Babraham Research Campus, Cambridge, United Kingdom, Cambridge,cambridgeshire Cb22 3at,united Kingdom
Phone
441223496069
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Cambridgeshire
Looking for a particular Axol Bioscience Ltd. employee's phone or email?

Axol Bioscience Ltd. Questions

News

Axol Bioscience Acquires Phenocell to Advance Human Disease Models - Business Wire

Axol Bioscience Acquires Phenocell to Advance Human Disease Models Business Wire

Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells - Lab Manager

Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells Lab Manager

Axol Bioscience Secures SMART Grant to Accelerate the Development of a Commercial iPSC-Powered ALS Models - BioInformant

Axol Bioscience Secures SMART Grant to Accelerate the Development of a Commercial iPSC-Powered ALS Models BioInformant

Axol Bioscience introduces multi-electrode array screening services for human iPSC-derived cells - News-Medical

Axol Bioscience introduces multi-electrode array screening services for human iPSC-derived cells News-Medical

Axol's Human iPSC-derived Microglia for neuroimmunology research - News-Medical

Axol's Human iPSC-derived Microglia for neuroimmunology research News-Medical

Axol Bioscience signs exclusive agreement with The Francis Crick Institute to license iPSC technology - BioInformant

Axol Bioscience signs exclusive agreement with The Francis Crick Institute to license iPSC technology BioInformant

How Human iPSCs are Revolutionizing Drug Discovery in 2025 - BioInformant

How Human iPSCs are Revolutionizing Drug Discovery in 2025 BioInformant

Top Axol Bioscience Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant